SEC EDGAR filings, ownership reports, and insider transactions for Bain Capital Life Sciences III General Partner, LLC.
Recent SEC filings for Bain Capital Life Sciences III General Partner, LLC including 13F-NT, 4, N-PX and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 17 Feb 2026 | 31 Dec 2025 | 028-22975 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Feb 2026 | 04 Feb 2026 | 001-42790 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Nov 2025 | 30 Sep 2025 | 028-22975 | |
| N-PX | Open N-PX document | View SEC filing for N-PX | 29 Aug 2025 | 30 Jun 2025 | 028-22975 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Aug 2025 | 30 Jun 2025 | 028-22975 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 13 Aug 2025 | 11 Aug 2025 | 001-42790 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 07 Aug 2025 | 07 Aug 2025 | 001-42790 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 May 2025 | 31 Mar 2025 | 028-22975 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Feb 2025 | 31 Dec 2024 | 028-22975 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Dec 2024 | 13 Dec 2024 | 001-41562 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Nov 2024 | 30 Sep 2024 | 028-22975 | |
| N-PX | Open N-PX document | View SEC filing for N-PX | 30 Aug 2024 | 30 Jun 2024 | 028-22975 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 12 Aug 2024 | 30 Jun 2024 | 028-22975 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 May 2024 | 31 Mar 2024 | 028-22975 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 14 Feb 2024 | 12 Feb 2024 | 001-41947 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 13 Feb 2024 | 31 Dec 2023 | 028-22975 | |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 07 Feb 2024 | 07 Feb 2024 | 001-41947 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 29 Dec 2023 | 29 Dec 2023 | 001-41562 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Nov 2023 | 30 Sep 2023 | 028-22975 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Aug 2023 | 30 Jun 2023 | 028-22975 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 May 2023 | 31 Mar 2023 | 028-22975 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Feb 2023 | 31 Dec 2022 | 028-22975 |
Bain Capital Life Sciences III General Partner, LLC files with the SEC under CIK 0001952106. This page aggregates EDGAR filings and related ownership activity.